Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-013796

Chief Executive Officer sold 8,009 shares at $243.23 ($1,948,003)

  • Chief Executive Officer acquired 8,009 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Farrell Michael J. Chief Executive Officer 2025-05-07 Option exercise 10b5-1 +8,009 $101.64 $814,035 463,512 D
Farrell Michael J. Chief Executive Officer 2025-05-07 Sale 10b5-1 −8,009 $243.23 $1,948,003 455,503 D
Derivatives
Farrell Michael J. Chief Executive Officer 2025-05-07 Option exercise · ResMed Common Stock Options 10b5-1 −8,009 48,056 D
Open-market sales · 8,009 sh · avg $243.23 · $1,948,003
Loading xslF345X05/form4.xml…